As the opioid crisis continues to grip the nation, it leaves another problem in its wake: drug testing fraud. For bad actors, opioid drug testing is an opportunity to exploit a crisis for extra reimbursement. While few of these schemes are new, detection can be slowed by siloed data. The good news is that information sharing and collaboration helps to catch these schemes faster, as we’ll explore in our upcoming webinar, Catching potential drug testing fraud: A case study of successful investigative techniques.
